Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Additionally, the Alzheimers Association released its first clinical practice guideline on the use of blood-based biomarkers in 2025, signaling that these tools are transitioning from research settings into real diagnostic pathways, grounding novel biomarkers into meaningful clinical action. Research into the treatment of Alzheimers disease continued to advance as well
Figure 3 5.2 Glial activation: amplifier of neurodegeneration Glial cells, including astrocytes, microglia, and oligodendrocytes, represent the principal non-neuronal population in the central nervous system and critically amplify neurodegenerative processes in PD, notably through their engagement in ferroptosis pathways
1 Buchst
B., Kinter, M
US$ 22.78
US$ 23.40
US$ 27.15
US$ 26.43
US$ 27.16
US$ 22.72
US$ 27.38
